Likewise, just $300 million would prevent 300,000 child deaths if it were used to strengthen the Global Fund’s Affordable Medicines Facility-malaria financing mechanism, which makes combination therapies cheaper for poor countries. Put in economic terms, the benefits are 35 times higher than the costs – even without taking into account that it safeguards our most effective malaria drug from future drug resistance.